Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05426356 · ClinicalTrials.gov registry record · NA
Sacral Fracture Fusion/Fixation for Rapid Rehabilitation
A NA study, sponsored by SI-BONE.
- Terminated
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT05426356: Clinical Trial NA study, sponsored by SI-BONE.
NCT05426356 is a NA study that was terminated before completion, run by SI-BONE. The registered enrollment target is 28 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05426356, a NA study, was terminated before completion, sponsored by SI-BONE.
- TERMINATED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
To determine the safety and efficacy of concomitant sacral fracture fixation and sacroiliac (SI) joint fusion vs. non-surgical management for patients with debilitating sacral fragility or insufficiency fractures
Primary Outcome
The study's primary efficacy endpoint is the time required to achieve an improvement from baseline (study entry) of 2 or more points on the Modified Functional Mobility scale. The scale is administered on a weekly basis following the initiation of treatment until achieving a 2-point improvement or the subject crosses over.
Interventions
- DEVICE Surgical Intervention
- OTHER Non-Surgical Management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2022-09-18 |
| Est. Completion | 2024-06-15 |
| Phase | NA |
Why NCT05426356 stopped before completion
NCT05426356 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Surgical Intervention is the first listed.
NCT05426356 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05426356 about?
NCT05426356 is a clinical study titled "Sacral Fracture Fusion/Fixation for Rapid Rehabilitation". To determine the safety and efficacy of concomitant sacral fracture fixation and sacroiliac (SI) joint fusion vs. non-surgical management for patients with debilitating sacral fragility or insufficiency fractures
What is the current status of trial NCT05426356?
This trial is currently terminated. It is a NA study. The enrollment target is 28 participants. The study started on 2022-09-18. Estimated completion is 2024-06-15.
What interventions are being tested in trial NCT05426356?
The interventions under investigation include: Surgical Intervention (DEVICE), Non-Surgical Management (OTHER).
Who is sponsoring clinical trial NCT05426356?
This trial is sponsored by SI-BONE, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05426356's enrollment target sits among peer trials
28 1704th of 2000 higher than 293 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI